Robichaud Albert is Chief Scientific Officer of Sage Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sage Therapeutics, Inc.
15 Feb 23
4
Sage Therapeutics, Inc.
7 Feb 23
4
Sage Therapeutics, Inc.
15 Feb 22
4
Sage Therapeutics, Inc.
21 Oct 21
4
Sage Therapeutics, Inc.
17 Jun 21
4
Sage Therapeutics, Inc.
12 Feb 21
4
Sage Therapeutics, Inc.
30 Apr 20
4
Sage Therapeutics, Inc.
14 Feb 20
4
Sage Therapeutics, Inc.
10 Dec 19
4
Sage Therapeutics, Inc.
29 Jul 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Feb 23 | SAGE Sage Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 45.28 | 16,720 | 757.08 k | 16,720 |
3 Feb 23 | SAGE Sage Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 44.16 | 1,127 | 49.77 k | 145,553 |
3 Feb 23 | SAGE Sage Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 3,375 | 0.00 | 146,680 |